Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BeEAC Conditioning in Malignant Lymphoma
NCT03315520Phase 2Unknown
- Start
- Jan 2016
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in malignant lymphoma. Status: unknown.
02
Drugs
bendamustine
03
Conditions
malignant lymphoma
Beyond the preview
Go deeper on NCT03315520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03315520.